The Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen binds to specific sequences at the left end of the viral genome through its carboxy-terminus

被引:100
作者
Cotter, MA
Subramanian, C
Robertson, ES [1 ]
机构
[1] Univ Michigan, Sch Med, Program Mol & Cellular Biol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA
关键词
D O I
10.1006/viro.2001.1202
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Latent infection by members of the gammaherpesvirus family is typically characterized by stable episomal maintenance of genomic viral DNA. In the case of Epstein-Barr virus (EBV), this is dependent upon binding of the Epstein-Barr nuclear antigen 1 (EBNA1) to sites which lie within the origin of plasmid replication (OriP). The recently discovered Kaposi's sarcoma-associated herpesvirus (KSHV) encodes the latency-associated nuclear antigen (LANA), which appears to be important for supporting the latent infection of human cells by KSHV. The present work describes site-specific binding of the LANA protein to multiple different elements at the left end of the genome, a region which appears to be critical for maintenance of KSHV episomes. Of the three sites, terminal LANA-binding region 4 (TLBR4) binds LANA with the highest affinity when compared to the other sites. Further characterization of this cis-acting element by mutagenesis studies indicates that the minimal TLBR4-binding sequence is represented by a 13-bp sequence 5' CGCCCGGGCATGG 3'. Furthermore, this specific binding to TLBR4 was mediated by the distal 200 amino acid C-terminus of the LANA protein. (C) 2001 Elsevier Science.
引用
收藏
页码:241 / 259
页数:19
相关论文
共 67 条
[21]   KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma [J].
Gao, SJ ;
Kingsley, L ;
Li, M ;
Zheng, W ;
Parravicini, C ;
Ziegler, J ;
Newton, R ;
Rinaldo, CR ;
Saah, A ;
Phair, J ;
Detels, R ;
Chang, Y ;
Moore, PS .
NATURE MEDICINE, 1996, 2 (08) :925-928
[22]   DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus [J].
Garber, AC ;
Shu, MA ;
Hu, JH ;
Renne, R .
JOURNAL OF VIROLOGY, 2001, 75 (17) :7882-7892
[23]   SEQUENCE REQUIREMENTS OF THE EPSTEIN-BARR-VIRUS LATENT ORIGIN OF DNA-REPLICATION [J].
HARRISON, S ;
FISENNE, K ;
HEARING, J .
JOURNAL OF VIROLOGY, 1994, 68 (03) :1913-1925
[24]   SIMULTANEOUS IDENTIFICATION OF BACTERIAL VIRULENCE GENES BY NEGATIVE SELECTION [J].
HENSEL, M ;
SHEA, JE ;
GLEESON, C ;
JONES, MD ;
DALTON, E ;
HOLDEN, DW .
SCIENCE, 1995, 269 (5222) :400-403
[25]   Maintenance of Epstein-Barr virus (EBV) oriP-based episomes requires EBV-encoded nuclear antigen-1 chromosome-binding domains, which can be replaced by high-mobility group-I or histone H1 [J].
Hung, SC ;
Kang, MS ;
Kieff, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (04) :1865-1870
[26]   Differential regulation of the overlapping Kaposi's sarcoma-associated herpesvirus vGCR (orf74) and LANA (orf73) promoters [J].
Jeong, J ;
Papin, J ;
Dittmer, D .
JOURNAL OF VIROLOGY, 2001, 75 (04) :1798-1807
[27]   Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus [J].
Kedes, DH ;
Lagunoff, M ;
Renne, R ;
Ganem, D .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (10) :2606-2610
[28]   The prevalence of serum antibody to human herpesvirus 8 (Kaposi sarcoma-associated herpesvirus) among HIV-seropositive and high-risk HIV-seronegative women [J].
Kedes, DH ;
Ganem, D ;
Ameli, N ;
Bacchetti, P ;
Greenblatt, R .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (06) :478-481
[29]   The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): Distribution of infection in KS risk groups and evidence for sexual transmission [J].
Kedes, DH ;
Operskalski, E ;
Busch, M ;
Kohn, R ;
Flood, J ;
Ganem, D .
NATURE MEDICINE, 1996, 2 (08) :918-924
[30]  
Kellam P, 1997, J Hum Virol, V1, P19